Mechanism Of Thermal Enhancement Research Articles

Anti-thermal quenching of luminescence in Y2W3O12:Yb3+/RE3+ (RE = Er/Ho/Tm) and its temperature sensing application.

Herein, a series of Y2W3O12:10%Yb3+/x%RE3+ (RE = Er/Ho/Tm) phosphors is prepared via a solid-state reaction. The upconversion and downshift luminescence properties of the phosphors were investigated under an excitation of 980 nm. The bright blue light emission from Tm3+ ion and the green and red light emissions from Ho3+(Er3+) ions were observed. The near-infrared light intensity of NIR-I (Tm3+, ∼850 nm), NIR-II (Er3+: ∼1550 nm; Tm3+: ∼1783 nm) and NIR-III (Ho3+: ∼2050 nm) were analyzed. In particular, the dramatic thermal enhancement phenomenon in visible and NIR regions was exhibited by the Y2W3O12:10%Yb3+/x%RE3+ (RE = Er/Ho/Tm) phosphors. Among them, the green light intensity of Er3+ ions increased 26.77 times, from 303 to 573 K. The NIR-II emission band (∼1783 nm) intensity of Tm3+ ions at 533 K increased 168.7 times compared to that at 313 K. The possible thermal enhancement mechanism is illustrated by the negative thermal expansion (NTE) and Frenkel defect of the Y2W3O12 host. Finally, the optical temperature sensing performances of Y2W3O12:10%Yb3+/x%RE3+ (RE = Er/Ho/Tm) samples are investigated according to the luminescence intensity dependence relationship on temperature. The maximum value of SR reached 4.24% K-1 at 353 K for Y2W3O12:10%Yb3+/0.6%Ho3+ phosphor. The results indicate that the Y2W3O12:10%Yb3+/x%RE3+ (RE = Er/Ho/Tm) phosphors possess anti-thermal quenching properties and are suitable for developing optical temperature sensors.

Exploration of Up-Conversion Thermal Enhancement Mechanism and Application on Temperature Sensing of Sc2w3o12: Yb3+, Er3+ Materials

Exploration of Up-Conversion Thermal Enhancement Mechanism and Application on Temperature Sensing of Sc2w3o12: Yb3+, Er3+ Materials

The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours

It has been shown that hyperthermia can enhance the cytotoxicity of some chemotherapeutics. However, the most effective agent(s) at elevated temperatures have yet to be determined. A previous study suggests that the drug of choice at elevated temperatures may be different from that at the physiological temperature, and that the alkylating agents may be most effective at elevated temperatures. To further investigate these possibilities, the effect of chemotherapeutic agents were compared. These agents were cyclophosphamide, ifosfamide, melphalan, cis-diamminedichloroplatinum (II), 5-fluorouracil, mitomycin C and bleomycin. Three tumours (mammary carcinoma, osteosarcoma and squamous cell carcinoma) were used. They were transplanted into the feet of C3H/He mice. When tumours reached 65 mm 3 , a test agent was injected intraperitoneally. Tumours were immediately heated at 41.5°C for 30 min, and the tumour growth (TG) time was studied for each tumour. Using the TG times, the TG-50 (the time required for one-half of the total number of the treated tumours to reach the volume of 800 mm 3 from 65 mm 3 ) was calculated. Subsequently, the tumour growth delay time (GDT) and the thermal enhancement ratio (TER) were obtained. The GDT was the difference between the TG-50 of treated tumours and that of non-treated control tumours. The TER was the ratio of the GDT of a group treated with an agent at 41.5°C to that of a group treated with the agent at room temperature. Results showed that the top three effective agents tested at 41.5°C were solely alkylating agents--CY, IFO and L-PAM--for each kind of tumour. A GDT of cisplatin was smaller than those of the alkylating agents. The smallest TER, 1.1, was observed for 5-fluorouracil, which was given for mammary carcinoma, and for mitomycin C, which was given for squamous cell carcinoma. It could be concluded that the alkylating agents at elevated temperatures might be the drugs of choice for many types of tumours. The possible mechanisms of thermal enhancement associated with these agents are discussed.